Bayer Avelox Skin Infection Indication "Approvable"; Needs More Safety Data
Executive Summary
Bayer's Avelox (moxifloxacin) is "approvable" for the treatment of uncomplicated skin and skin structure infections, FDA said in a Dec. 10 letter granting the antibiotic approval for three other indications.